241 related articles for article (PubMed ID: 30070700)
41. The "Medicare effect" on head and neck cancer diagnosis and survival.
Smith JB; Jayanth P; Hong SA; Simpson MC; Massa ST
Head Neck; 2023 Jul; 45(7):1663-1675. PubMed ID: 37096786
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
43. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
[TBL] [Abstract][Full Text] [Related]
44. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
Sher DJ; Neville BA; Chen AB; Schrag D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
[TBL] [Abstract][Full Text] [Related]
45. Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
Jin MC; Harris JP; Sabolch AN; Gensheimer M; Le QT; Beadle BM; Pollom EL
Laryngoscope; 2020 Nov; 130(11):E598-E604. PubMed ID: 31837165
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
Kao J; Lavaf A; Teng MS; Huang D; Genden EM
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
[TBL] [Abstract][Full Text] [Related]
47. Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database.
Li X; Guo K; Feng Y; Guo Y
Cancer Med; 2020 Nov; 9(21):8029-8042. PubMed ID: 32931661
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
49. Disparities in surgery for early-stage cancer: the impact of refusal.
Rapp J; Tuminello S; Alpert N; Flores RM; Taioli E
Cancer Causes Control; 2019 Dec; 30(12):1389-1397. PubMed ID: 31630307
[TBL] [Abstract][Full Text] [Related]
50. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of level V metastasis in head and neck squamous cell carcinoma.
Kainuma K; Yano T; Kitoh R; Naito T; Usami S
Acta Otolaryngol; 2013 Feb; 133(2):218-24. PubMed ID: 23145939
[TBL] [Abstract][Full Text] [Related]
52. Comorbidity as a major risk factor for mortality and complications in head and neck surgery.
Ferrier MB; Spuesens EB; Le Cessie S; Baatenburg de Jong RJ
Arch Otolaryngol Head Neck Surg; 2005 Jan; 131(1):27-32. PubMed ID: 15655181
[TBL] [Abstract][Full Text] [Related]
53. Effect of preoperative immunonutrition on complications after salvage surgery in head and neck cancer.
Mueller SA; Mayer C; Bojaxhiu B; Aeberhard C; Schuetz P; Stanga Z; Giger R
J Otolaryngol Head Neck Surg; 2019 May; 48(1):25. PubMed ID: 31151486
[TBL] [Abstract][Full Text] [Related]
54. Small cell carcinoma of the head and neck: A comparative study by primary site based on population data.
Kuan EC; Alonso JE; Tajudeen BA; Arshi A; Mallen-St Clair J; St John MA
Laryngoscope; 2017 Aug; 127(8):1785-1790. PubMed ID: 27859290
[TBL] [Abstract][Full Text] [Related]
55. Readmission after surgery for oropharyngeal cancer: An analysis of rates, causes, and risk factors.
Goel AN; Badran KW; Mendelsohn AH; Chhetri DK; Sercarz JA; Blackwell KE; John MAS; Long JL
Laryngoscope; 2019 Apr; 129(4):910-918. PubMed ID: 30229931
[TBL] [Abstract][Full Text] [Related]
56. Gastroesophageal reflux disease and odds of head and neck squamous cell carcinoma in North Carolina.
Busch EL; Zevallos JP; Olshan AF
Laryngoscope; 2016 May; 126(5):1091-6. PubMed ID: 26451875
[TBL] [Abstract][Full Text] [Related]
57. The role of elective neck dissection in the treatment of maxillary sinus squamous cell carcinoma.
Sangal NR; Lee YJ; Brady JS; Patel TD; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2018 Aug; 128(8):1835-1841. PubMed ID: 29193120
[TBL] [Abstract][Full Text] [Related]
58. Update on adherence to guidelines for time to initiation of postoperative radiation for head and neck squamous cell carcinoma.
Lorenz FJ; Mahase SS; Miccio J; King TS; Pradhan S; Goyal N
Head Neck; 2023 Jul; 45(7):1676-1691. PubMed ID: 37102787
[TBL] [Abstract][Full Text] [Related]
59. A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer.
Tang Y; Gao Y; Zhang R; Li T; Yang Y; Huang L; Wei Y
Sci Rep; 2024 Apr; 14(1):9494. PubMed ID: 38664545
[TBL] [Abstract][Full Text] [Related]
60. Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: a SEER-Medicare database study.
Stott-Miller M; Chen C; Schwartz SM
Cancer Epidemiol; 2013 Aug; 37(4):428-33. PubMed ID: 23562170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
